{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:36Z","timestamp":1707524436315},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,30]]},"DOI":"10.7759\/cureus.21743","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:19:45Z","timestamp":1643588385000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase A1298C Polymorphism"],"prefix":"10.7759","author":[{"given":"Anna","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra","family":"Struble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00057","article-title":"Update on management of portal vein thrombosis and the role of novel anticoagulants","volume":"7","author":"Wu M","year":"2019","unstructured":"Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol. 2019, 7:154-64. 10.14218\/JCTH.2018.00057","journal-title":"J Clin Transl Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i2.143","article-title":"Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment","volume":"16","author":"Ponziani FR","year":"2010","unstructured":"Ponziani FR, Zocco MA, Campanale C, et al.. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010, 16:143-55. 10.3748\/wjg.v16.i2.143","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2014.10.004","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases","volume":"58","author":"Liew SC","year":"2015","unstructured":"Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015, 58:1-10. 10.1016\/j.ejmg.2014.10.004","journal-title":"Eur J Med Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.121.316397","article-title":"Homocysteine is associated with future venous thromboembolism in 2 prospective cohorts of women","volume":"41","author":"Aday AW","year":"2021","unstructured":"Aday AW, Duran EK, Van Denburgh M, et al.. Homocysteine is associated with future venous thromboembolism in 2 prospective cohorts of women. Arterioscler Thromb Vasc Biol. 2021, 41:2215-24. 10.1161\/ATVBAHA.121.316397","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","author":"Undas A","year":"2005","unstructured":"Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost. 2005, 94:907-15. 10.1160\/TH05-05-0313","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.003","article-title":"Portal vein thrombosis, revisited","volume":"42","author":"Primignani M","year":"2010","unstructured":"Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010, 42:163-70. 10.1016\/j.dld.2009.08.003","journal-title":"Dig Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani R","year":"2010","unstructured":"Rajani R, Bj\u00f6rnsson E, Bergquist A, et al.. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010, 32:1154-62. 10.1111\/j.1365-2036.2010.04454.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve LD","year":"2009","unstructured":"DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009, 49:1729-64. 10.1002\/hep.22772","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013311","article-title":"Homocysteine and MTHFR mutations","volume":"132","author":"Moll S","year":"2015","unstructured":"Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation. 2015, 132:e6-9. 10.1161\/CIRCULATIONAHA.114.013311","journal-title":"Circulation"},{"key":"ref10","unstructured":"Final diagnosis - wild-type MTHFR 677 genotype. Accessed. August 20, 2021: https:\/\/path.upmc.edu\/cases\/case677\/dx.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease","volume":"103","author":"Poddar R","year":"2001","unstructured":"Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001, 103:2717-23. 10.1161\/01.cir.103.22.2717","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.17.10.2074","article-title":"Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells","volume":"17","author":"Majors A","year":"1997","unstructured":"Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997, 17:2074-81. 10.1161\/01.atv.17.10.2074","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5505\/ejm.2020.81905","article-title":"Hereditary thrombophilia risk factors in patients with venous thromboembolism","volume":"25","author":"Destek S","year":"2020","unstructured":"Destek S, Gul VO. Hereditary thrombophilia risk factors in patients with venous thromboembolism. East J Med. 2020, 25:26-32. 10.5505\/ejm.2020.81905","journal-title":"East J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2008.1.39","article-title":"Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians","volume":"49","author":"Spiroski I","year":"2008","unstructured":"Spiroski I, Kedev S, Antov S, et al.. Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians. Croat Med J. 2008, 49:39-49. 10.3325\/cmj.2008.1.39","journal-title":"Croat Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610385224","article-title":"Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis","volume":"17","author":"Kupeli E","year":"2011","unstructured":"Kupeli E, Verdi H, Simsek A, Atac FB, Eyuboglu FO. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis. Clin Appl Thromb Hemost. 2011, 17:E87-94. 10.1177\/1076029610385224","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(99)00157-7","article-title":"Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients","volume":"97","author":"Akar N","year":"2000","unstructured":"Akar N, Akar E, Ak\u00e7ay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res. 2000, 97:163-7. 10.1016\/s0049-3848(99)00157-7","journal-title":"Thromb Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73011-a-case-of-portal-vein-thrombosis-in-a-patient-with-methylenetetrahydrofolate-reductase-a1298c-polymorphism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:09Z","timestamp":1707507429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73011-a-case-of-portal-vein-thrombosis-in-a-patient-with-methylenetetrahydrofolate-reductase-a1298c-polymorphism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.21743","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,30]]}}}